Weak Peptide Agonists Reveal Functional Differences in B7-1 and B7-2 Costimulation of Human T Cell Clones

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 1669-1675

  Anderson, David E ^a   Ausubel, Lara J ^a   Krieger, Jeff ^b   Höllsberg, Per ^a   Freeman, Gordon J ^c   Hafler, David A ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b AutoImmune Inc   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; CYTOKINE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MYELIN BASIC PROTEIN; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; CELL CLONE; CHO CELL; HAMSTER; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; PHYSIOLOGY; SECRETION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; AUTOIMMUNE DISEASES; CHO CELLS; CLONE CELLS; CRICETINAE; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 0031571214     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
2. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1995. The critical role of CD28 signalling in the prevention of human T-cell anergy. Res. Immunol. 146:140.
3. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
4. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
5. Windhagen, A., C. Scholz, P. Höllsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
6. Vyth-Dreese, F. A., T. A. M. Dellemijn, D. Majoor, and D. de Jong. 1995. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Eur. J. Immunol. 25:3023.
7. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
8. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985.
9. Williams, K., E. Ulvestad, and J. P. Antel. 1994. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:3031.
10. Sloan-Lancaster, J., and P. M. Allen. 1995. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:103.
11. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
12. Ausubel, L. J., C. K. Kwan, A. Sette, V. Kuchroo, and D. A. Hafler. 1996. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc. Natl. Acad. Sci. USA 93:15317.
13. Vidal, K., B. L. Hsu, C. B. Williams, and P. M. Allen. 1996. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183:1311.
14. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
15. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
16. Scholz, C., G. J. Freeman, E. A. Greenfield, D. A. Hafler, and P. Höllsberg. 1996. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation. J. Immunol. 157:2932.
17. + T cells. J. Exp. Med. 182:1591.
18. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1579.
19. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
20. Dangond, F., A. Windhagen, C. J. Groves, and D. A. Hafler. 1997. Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J. Neuroimmunol. In Press.